Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)
Never self-injected before
How SeekPeptides supports regenerative protocols SeekPeptides provides comprehensive resources for understanding and implementing BPC-157 and TB-500 combination protocols
Their high antioxidant content helps combat oxidative stress, preventing premature ageing and dullness
For the interactive floor plan, please click here
In such cases, supplementation may be considered under the guidance of a healthcare professional